Brief: Theravance Biopharma Inc Reports Third Quarter 2022 Financial Results

Theravance Biopharma

07/11/2022 22:20

Nov 7 (Reuters) - Theravance Biopharma Inc  TBPH.O :
    * THERAVANCE BIOPHARMA, INC. REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS, PROVIDES BUSINESS UPDATE AND EXTENDS TENDER OFFER
    * QTRLY NET SALES $18.7 MILLION UP 35%
    * QTRLY LOSS PER SHARE FROM CONTINUING OPERATIONS $0.21
    * Q3 EARNINGS PER SHARE VIEW $-0.18, REVENUE VIEW $11.8
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nPn245QXZa 
Further company coverage:  TBPH.O 
 ((Reuters.Briefs@thomsonreuters.com;))